Diaphanous 1 (DIAPH1) is Highly Expressed in the Aged Human Medial Temporal Cortex and Upregulated in Myeloid Cells During Alzheimer's Disease

• Published in: Journal of Alzheimer's disease Vol. 64; no. 3; p. 995
• Main Authors: Derk, Julia, Bermudez Hernandez, Keria, Rodriguez, Moises, He, Meilun, Koh, Hyunwook, Abedini, Andisheh, Li, Huilin, Fenyö, David, Schmidt, Ann Marie
• Format: Journal Article
• Language: English
• Published: Netherlands 01.01.2018
• Subjects: Adaptor Proteins, Signal Transducing - genetics; Adaptor Proteins, Signal Transducing - metabolism; Aged; Aged, 80 and over; Aging - pathology; Alzheimer Disease - genetics; Alzheimer Disease - pathology; Animals; Apolipoproteins E - genetics; Case-Control Studies; Claudin-1 - metabolism; Female; Formins; Glial Fibrillary Acidic Protein - metabolism; Humans; Imaging, Three-Dimensional; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microscopy, Confocal; Microtubule-Associated Proteins - metabolism; Myeloid Cells - metabolism; Receptor for Advanced Glycation End Products - metabolism; Temporal Lobe - metabolism; Up-Regulation - physiology; DIAPH1; lipids; myeloid cells; Alzheimer’s disease; inflammation; RAGE; microglia
• ISSN: 1875-8908
• DOI: 10.3233/JAD-180088

The receptor for advanced glycation end products (RAGE) is linked to cellular stress and inflammation during Alzheimer's disease (AD). RAGE signals through Diaphanous-1 (DIAPH1); however, the expression of DIAPH1 in the healthy and AD human brain has yet to be methodically addressed. To delineate the cell- and disease-state specific expression of DIAPH1 in the human medial temporal cortex during healthy aging and AD. We used semi-quantitative immunohistochemistry in the human medial temporal cortex paired with widefield and confocal microscopy and automated analyses to determine colocalization and relative expression of DIAPH1 with key cell markers and molecules in the brains of subjects with AD versus age-matched controls. We report robust colocalization of DIAPH1 with myeloid cells and increased expression during AD, which strongly correlated to increased neutral lipids and morphology of inflamed myeloid cells. DIAPH1 moderately colocalized with markers of endothelial cells, astrocytes, neurons, and oligodendrocytes. Our findings localize DIAPH1 particularly to myeloid cells in the CNS, especially in AD in the locations of lipid droplet accumulation, thereby implicating RAGE-DIAPH1 signaling in dysregulated lipid metabolism and morphological changes of inflamed myeloid cells in this disorder.